126 related articles for article (PubMed ID: 37995304)
1. Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization.
Castillo P; Castrejon N; Marginet M; Massi D; Alamon F; Teixido C; Montironi C; Garcia-Herrera A; Albero-Gonzalez R; Matas J; Puig S; Alos L
Clin Exp Dermatol; 2024 Mar; 49(4):356-363. PubMed ID: 37995304
[TBL] [Abstract][Full Text] [Related]
2. Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing.
Ebbelaar CF; Schrader AMR; van Dijk M; Meijers RWJ; de Leng WWJ; Bloem LT; Jansen AML; Blokx WAM;
Mod Pathol; 2022 Aug; 35(8):1110-1120. PubMed ID: 35184152
[TBL] [Abstract][Full Text] [Related]
3. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
4. The plexiform spindle cell nevus nevi and atypical variants: report of 128 cases.
Hung T; Yang A; Mihm MC; Barnhill RL
Hum Pathol; 2014 Dec; 45(12):2369-78. PubMed ID: 25300464
[TBL] [Abstract][Full Text] [Related]
5. The WHO 2018 Classification of Cutaneous Melanocytic Neoplasms: Suggestions From Routine Practice.
Ferrara G; Argenziano G
Front Oncol; 2021; 11():675296. PubMed ID: 34277420
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of atypical deep penetrating nevus progressing to melanoma.
Isales MC; Khan AU; Zhang B; Compres EV; Kim D; Tan TL; Beaubier N; Gerami P
J Cutan Pathol; 2020 Dec; 47(12):1150-1154. PubMed ID: 32526042
[TBL] [Abstract][Full Text] [Related]
7. An Atypical Deep Penetrating Nevus With Mutations in Beta Catenin , BRAFV600E , and IDH1R132C in an 8-Year-Old Boy.
Ireland AM; Wood BA; Whitfield J; Amanuel B; Harvey NT; Mesbah Ardakani N
Am J Dermatopathol; 2022 Aug; 44(8):607-610. PubMed ID: 35385855
[TBL] [Abstract][Full Text] [Related]
8. Orbital meningeal melanocytoma: Histological, immunohistochemical and molecular characterization of a case and review of the literature.
Palicelli A; Disanto MG; Panzarasa G; Veggiani C; Galizia G; Dal Cin S; Gruppioni E; Boldorini R
Pathol Res Pract; 2016 Oct; 212(10):946-953. PubMed ID: 27499153
[TBL] [Abstract][Full Text] [Related]
9. Combined deep penetrating nevi of the conjunctiva are relatively common lesions characterised by BRAFV600E mutation and activation of the beta catenin pathway: a clinicopathological analysis of 34 lesions.
Šekoranja D; Vergot K; Hawlina G; Pižem J
Br J Ophthalmol; 2020 Jul; 104(7):1016-1021. PubMed ID: 31558492
[TBL] [Abstract][Full Text] [Related]
10. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls.
Vanderbeck K; Rothrock AT; Cho WC; Nagarajan P; Aung PP; Hudgens C; Bassett RL; Ivan D; Prieto VG; Curry JL; Torres-Cabala CA
Am J Dermatopathol; 2023 Aug; 45(8):549-556. PubMed ID: 37462205
[TBL] [Abstract][Full Text] [Related]
11. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and prognosis of nodal nevi].
Hu J; Ren M; Cai X; Shen XX; Dai B; Kong YY
Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):494-499. PubMed ID: 33915657
[No Abstract] [Full Text] [Related]
13. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
Garola R; Singh V
Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
[TBL] [Abstract][Full Text] [Related]
15. NGS-Based Analysis of Atypical Deep Penetrating Nevi.
Manca A; Sini MC; Cesinaro AM; Portelli F; Urso C; Lentini M; Cardia R; Alos L; Cook M; Simi S; Paliogiannis P; De Giorgi V; Cossu A; Palmieri G; Massi D
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205480
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous melanocytoma mimicking a lipoma: a rare presentation of a rare neoplasm with histological, immunohistochemical, cytogenetic and molecular characterization.
Marwaha N; Batanian JR; Coppens JR; Pierson MJ; Richards-Yutz J; Ebrahimzadeh J; Ganguly A; Guzman MA
J Cutan Pathol; 2016 Dec; 43(12):1186-1196. PubMed ID: 27573466
[TBL] [Abstract][Full Text] [Related]
17. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
[TBL] [Abstract][Full Text] [Related]
18. Desmoplastic Melanoma as a Diagnostic Pitfall.
Zindanci I; Zemheri E; Kevser Uzuncakmak T; Akdeniz N; Serap Karadag A; Kavala M; Can B; Turkoglu Z
Acta Dermatovenerol Croat; 2020 Jul; 28(1):49-50. PubMed ID: 32650855
[TBL] [Abstract][Full Text] [Related]
19. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Ramani NS; Aung PP; Gu J; Sfamenos S; Sdringola-Maranga C; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Diab A; Prieto VG; Hwu WJ; Torres-Cabala CA
Mod Pathol; 2020 Oct; 33(10):2067-2074. PubMed ID: 32404956
[TBL] [Abstract][Full Text] [Related]
20. Simulants of Malignant Melanoma.
Piérard GE; Piérard-Franchimont C; Delvenne P
Oncol Rev; 2015 Feb; 9(1):278. PubMed ID: 26779311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
